Active Pharmacovigilance in COVID-19 Patients: The Role of a Clinical Pharmacist in the Reporting of Adverse Drug Events

被引：0
|
作者：
Hida, A. [1 ,2 ]
Faroudy, M. [1 ,3 ]
Chaibi, A. [1 ,2 ]
Cadi, M. A. E. [1 ,2 ]
机构：
[1] Mohamed V Souissi Univ, Fac Med & Pharm Rabat, Rabat, Morocco
[2] Ibn Sina Univ Hosp, Dept Pharm, Rabat, Morocco
[3] Ibn Sina Univ Hosp, Intens Care Unit, Emergency Trauma Dept, Rabat, Morocco
来源：
DRUG SAFETY | 2022年 / 45卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
P158
引用
收藏
页码：1200 / 1200
页数：1
相关论文
共 50 条
  • [41] Ivermectin associated adverse events in the treatment and prevention of COVID-19 reported to the FACT pharmacovigilance project
    Farah, Rita
    Kazzi, Ziad
    Brent, Jeffrey
    Burkhart, Keith
    Wax, Paul
    Aldy, Kim
    CLINICAL TOXICOLOGY, 2022, 60 (08) : 942 - 946
  • [42] Drug safety in patients treated for COVID-19: A French pharmacovigilance survey
    Grandvuillemin, A.
    Destere, A.
    Rabier, M. B. Valnet
    Dautriche, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 : 38 - 38
  • [43] An observational, retrospective, comprehensive pharmacovigilance analysis of hydroxychloroquine-associated cardiovascular adverse events in patients with and without COVID-19
    Min Luo
    Bin Wu
    Yuwen Li
    Fengbo Wu
    International Journal of Clinical Pharmacy, 2022, 44 : 1179 - 1187
  • [44] An observational, retrospective, comprehensive pharmacovigilance analysis of hydroxychloroquine-associated cardiovascular adverse events in patients with and without COVID-19
    Luo, Min
    Wu, Bin
    Li, Yuwen
    Wu, Fengbo
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (05) : 1179 - 1187
  • [45] Pharmacovigilance Before and After COVID-19 Pandemic: A 3-Years Analysis of Adverse Drug Reactions Reporting at the University Hospital of Catania
    Brancati, S.
    Ruscica, R.
    Gozzo, L.
    Longo, L.
    Vitale, D. C.
    Drago, F.
    DRUG SAFETY, 2022, 45 (10) : 1213 - 1213
  • [46] Impact of Covid-19 Vaccination on Spontaneous Pharmacovigilance Reporting in France
    Sibylle de Germay
    Allison Singier
    Francesco Salvo
    Antoine Pariente
    Drug Safety, 2023, 46 : 1381 - 1389
  • [47] Impact of Covid-19 Vaccination on Spontaneous Pharmacovigilance Reporting in France
    de Germay, Sibylle
    Singier, Allison
    Salvo, Francesco
    Pariente, Antoine
    French Pharmacovigilance Network
    DRUG SAFETY, 2023, 46 (12) : 1381 - 1389
  • [48] Impact of COVID-19 vaccination on pharmacovigilance spontaneous reporting in France
    De Germay, S.
    Singier, A.
    Salvo, F.
    Pariente, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 18 - 19
  • [49] ADVERSE DRUG-REACTIONS REPORTING IMPROVED BY CLINICAL PHARMACIST ACTIVITIES
    PARDO, C
    MAS, MP
    SAGALES, M
    SANCHEZ, F
    MERCADE, V
    PUJOL, R
    PROGRESS IN CLINICAL PHARMACY: RATIONAL USE OF DRUGS, 1989, : 286 - 287
  • [50] Ocular inflammatory events following COVID-19 vaccination: reporting of suspected adverse drug reactions to regulatory authorities in the UK
    Testi, Ilaria
    Soomro, Taha
    Pavesio, Carlos
    Solebo, Ameenat Lola
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2024, 108 (09) : 1200 - 1203
12345